These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 10872562
1. Markers of electrical instability in hypertensive patients with and without ventricular arrhythmias. Are they useful in identifying patients with different risk profiles? Facchini M, Malfatto G, Ciambellotti F, Riva B, Bragato R, Branzi G, Leonetti G. J Hypertens; 2000 Jun; 18(6):763-8. PubMed ID: 10872562 [Abstract] [Full Text] [Related]
2. [QT dispersion and characteristics of left ventricular hypertrophy in primary hypertension]. Szymański L, Mandecki T, Twardowski R, Mizia-Stec K, Szulc A, Jastrzebska-Maj E. Pol Arch Med Wewn; 2002 Jan; 107(1):19-27. PubMed ID: 12046340 [Abstract] [Full Text] [Related]
3. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. Perkiömäki JS, Ikäheimo MJ, Pikkujämsä SM, Rantala A, Lilja M, Kesäniemi YA, Huikuri HV. Hypertension; 1996 Jul; 28(1):16-21. PubMed ID: 8675257 [Abstract] [Full Text] [Related]
4. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension]. Franchi F, Michelucci A, Padeletti L, Monopoli A, Fabbri G, Cersosimo RM, Mezzani A. G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391 [Abstract] [Full Text] [Related]
5. QT dispersion and hypertensive heart disease in the elderly. Gryglewska B, Grodzicki T, Czarnecka D, Kawecka-Jaszcz K, Kocemba J. J Hypertens; 2000 Apr; 18(4):461-4. PubMed ID: 10779098 [Abstract] [Full Text] [Related]
6. QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy. Piccirillo G, Germanò G, Quaglione R, Nocco M, Lintas F, Lionetti M, Moisè A, Ragazzo M, Marigliano V, Cacciafesta M. Clin Sci (Lond); 2002 Mar; 102(3):363-71. PubMed ID: 11869178 [Abstract] [Full Text] [Related]
7. Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction. Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Wachtell K, Papademetriou V, Jern S, Dahlöf B, Devereux RB, Okin PM. J Hypertens; 2001 Oct; 19(10):1883-91. PubMed ID: 11593111 [Abstract] [Full Text] [Related]
8. QT dispersion and left ventricular hypertrophy in elderly hypertensive and normotensive patients. Dimopoulos S, Nicosia F, Donati P, Prometti P, De Vecchi M, Zulli R, Grassi V. Angiology; 2008 Oct; 59(5):605-12. PubMed ID: 18388029 [Abstract] [Full Text] [Related]
10. [The relation between QT dispersion and incidence of ventricular premature beats in patients after myocardial infarction]. Dabrowski A, Kramarz E. Pol Arch Med Wewn; 2001 Apr; 105(4):279-83. PubMed ID: 11761798 [Abstract] [Full Text] [Related]
11. Increased left ventricular dimensions in patients with frequent nonsustained ventricular arrhythmia and no evidence of underlying heart disease. Facchini M, Malfatto G, Ciambellotti F, Chianca R, Bragato R, Branzi G, Leonetti G. J Cardiovasc Electrophysiol; 1999 Nov; 10(11):1433-8. PubMed ID: 10571363 [Abstract] [Full Text] [Related]
12. Prognostic value of ventricular arrhythmias in systemic hypertension. Galinier M, Balanescu S, Fourcade J, Dorobantu M, Boveda S, Massabuau P, Cabrol P, Dongay B, Fauvel JM, Bounhoure JP. J Hypertens; 1997 Dec; 15(12 Pt 2):1779-83. PubMed ID: 9488239 [Abstract] [Full Text] [Related]
13. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy]. Akdeniz B, Güneri S, Badak O, Aslan O, Tamci B. Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537 [Abstract] [Full Text] [Related]
14. [Arterial hypertension, left ventricular hypertrophy and arrhythmias]. González Maqueda I. Rev Esp Cardiol; 1991 Nov; 44(9):586-98. PubMed ID: 1723211 [Abstract] [Full Text] [Related]
16. Ventricular arrhythmias in hypertension: in which patients do they occur? Mayet J, Shahi M, Poulter NR, Sever PS, Thom SA, Foale RA. J Hypertens; 1995 Feb; 13(2):269-76. PubMed ID: 7615959 [Abstract] [Full Text] [Related]
17. Impaired left ventricular filling in hypertensive left ventricular hypertrophy as a marker of the presence of an arrhythmogenic substrate. Palatini P, Maraglino G, Accurso V, Sturaro M, Toniolo G, Dovigo P, Baccillieri S. Br Heart J; 1995 Mar; 73(3):258-62. PubMed ID: 7727186 [Abstract] [Full Text] [Related]
18. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA). Malmqvist K, Kahan T, Edner M, Bergfeldt L. Am J Cardiol; 2002 Nov 15; 90(10):1107-12. PubMed ID: 12423712 [Abstract] [Full Text] [Related]
19. [Prognostic value of ventricular arrhythmia in hypertensive patients]. Galinier M, Balanescu S, Fourcade J, Dorobantu M, Massabuau P, Dongay B, Cabrol P, Fauvel JM, Bounhoure JP. Arch Mal Coeur Vaiss; 1997 Aug 15; 90(8):1049-53. PubMed ID: 9404407 [Abstract] [Full Text] [Related]
20. Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction. Passino C, Magagna A, Conforti F, Buralli S, Kozáková M, Palombo C, Emdin M. J Hypertens; 2003 Feb 15; 21(2):445-51. PubMed ID: 12569277 [Abstract] [Full Text] [Related] Page: [Next] [New Search]